Cane Capital Partners LLC Makes New Investment in Humana Inc. $HUM

Cane Capital Partners LLC acquired a new stake in Humana Inc. (NYSE:HUM) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 1,299 shares of the insurance provider’s stock, valued at approximately $225,000.

Other institutional investors also recently modified their holdings of the company. Long Focus Capital Management LLC acquired a new position in Humana during the 3rd quarter valued at about $34,212,000. Aberdeen Group plc boosted its position in shares of Humana by 18.1% during the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after buying an additional 43,442 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Humana by 4.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares in the last quarter. Ninety One UK Ltd grew its holdings in Humana by 57.2% during the fourth quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock worth $28,815,000 after buying an additional 40,958 shares in the last quarter. Finally, Sustainable Insight Capital Management LLC raised its position in Humana by 23.7% in the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after buying an additional 4,740 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Performance

NYSE HUM opened at $409.92 on Thursday. The company has a 50-day simple moving average of $314.71 and a two-hundred day simple moving average of $248.64. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $414.82. The firm has a market cap of $49.22 billion, a price-to-earnings ratio of 43.84, a PEG ratio of 2.26 and a beta of 0.71.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same period last year, the company earned $11.58 EPS. Humana’s revenue for the quarter was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts forecast that Humana Inc. will post 9.04 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

Analyst Ratings Changes

A number of brokerages have issued reports on HUM. JPMorgan Chase & Co. upped their price objective on shares of Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research report on Monday, June 8th. Morgan Stanley boosted their target price on Humana from $217.00 to $249.00 and gave the stock an “underweight” rating in a research note on Thursday, June 4th. Robert W. Baird decreased their price target on Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. William Blair assumed coverage on Humana in a report on Wednesday, May 20th. They set an “outperform” rating on the stock. Finally, Truist Financial raised their target price on Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $293.09.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.